Gabelli Funds LLC Aptinyx Inc. Transaction History

Gabelli Funds LLC

  • $12.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020
SELL
$1.99 - $4.4 $9,950 - $22,000
-5,000 Reduced 31.44%
10,901 $45,000
Q2 2019

Aug 02, 2019
BUY
$2.95 - $4.38 $14,750 - $21,900
5,000 Added 45.87%
15,901 $53,000
Q1 2019

May 02, 2019
BUY
$3.99 - $19.33 $43,494 - $210,716
10,901 New
10,901 $44,000

About Aptinyx Inc.

APTX Quotes by TradingView
  • Ticker APTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,715,696
  • Description
  • Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...
More about APTX
Track This Portfolio

Track Gabelli Funds LLC Portfolio

Follow Gabelli Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email